The Transatlantic Medtech Investment Gap: Why Does it Exist and Can it be Plugged?
By Ivor Campbell – The medical technology sector has long been characterized as the steady, reliable engine of the life sciences world. A sector offering consistent growth, without the wild volatility and boom-or-bust narratives of biotech or the frothy hype of digital health, it may be seen by some as “vanilla”, but it also has the benefit of being robust.
Read More